arrow
S

Sebastian Bauer

University Duisburg-Essen
H指数:70
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy, clinical outcomes, and safety of vimseltinib in patients with tenosynovial giant cell tumor: results from the MOTION phase 3 trial

维美替尼在腱鞘巨细胞瘤患者中的长期疗效、临床结局及安全性:MOTION III期试验结果

2026-10-190
OAAI
Nilotinib revisited in GIST: salvage use in patients with severe imatinib toxicity

尼洛替尼在胃肠间质瘤中的重新评估:严重伊马替尼毒性患者的挽救性应用

2026-09-030
OAAI
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor

多层分子分析为硬化性小圆细胞肿瘤的诊断和靶向治疗提供信息

2026-04-090
OA
[68Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[18F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational Study

Bartel, T.; Pabst, K.M.; Barg, C.; Berliner, C.A.; Hamacher, R.; Bauer, S.; Falkenhorst, J.; Kessler, L.; Nader, M.; Barbato, F.; 等. [(68)Ga]Ga-FAPI-46 PET/CT在胃肠间质瘤患者中的应用,与2-[(18)F]FDG PET/CT及增强CT的比较:一项前瞻性观察研究的成果. J. Nucl. Med. 2025, 67, 210–216. [Google Scholar] [CrossRef]

2026-02-012
PRE
Exceptional therapeutic benefit of imatinib in cKIT-mutated mucosal melanoma followed by a KIT mutation loss

cKIT突变黏膜黑色素瘤中伊马替尼的显著治疗获益及其随后发生的KIT突变丢失

2025-10-250
OAAI
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratification

利用自动CT体成分分析杠杆化肌肉减少症指数,用于泛癌种预后分层。

2025-10-140
OA
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial

CDK4/6抑制剂在晚期软骨肉瘤中的应用:NCT PMO-1601试验的最终结果

2025-07-070
OA
Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study

培非达artinib在腱鞘巨细胞瘤患者中的长期有效性与安全性:ENLIVEN研究的最终结果

2025-07-014
PRE
The sarcoma ring trial: a case-based analysis of inter-center agreement across 21 German-speaking sarcoma centers (vol 151, 30, 2024)

软组织肉瘤环状试验:一项基于病例的分析,评估德国21个讲德语的软组织肉瘤中心之间的中心间一致性(卷151,期30,2024)

2025-04-240
OA
Assessment of the physiological effects and safety of transpulmonary chemoembolization with doxorubicin on pulmonary tissue using a human-isolated lung perfusion model

基于人源离体肺灌注模型对多柔比星经肺化疗栓塞术在肺组织中的生理效应及安全性评估

2024-12-050
OAAI
The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11+17/18 mutations

INSIGHT研究: 瑞替尼与舒尼替尼治疗KIT外显子11 17/18突变的晚期胃肠道间质瘤的随机III期研究

2024-09-042
OAAI
Updated efficacy and safety of vimseltinib in patients (pts) with tenosynovial giant cell tumor (TGCT): One-year follow-up from the MOTION phase III trial

更新后的vimelstinib在腱鞘巨细胞瘤(TGCT)患者中的疗效与安全性:MOTION III期试验的一年随访结果

2024-09-010
PRE
Primary pulmonary sarcoma: A EURACAN project

原发性肺肉瘤:一项EURACAN项目

2024-09-010
PRE